These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7741637)

  • 1. Vascular prostheses for aortocoronary bypass grafting: a review.
    Tomizawa Y
    Artif Organs; 1995 Jan; 19(1):39-45. PubMed ID: 7741637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prosthetic conduits in coronary artery bypass grafting.
    Desai M; Seifalian AM; Hamilton G
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):394-8. PubMed ID: 21216613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term patency of polytetrafluoroethylene vascular grafts in coronary artery surgery.
    Murtra M; Mestres CA; Igual A
    Ann Thorac Surg; 1985 Jan; 39(1):86-7. PubMed ID: 3871323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortocoronary vascular prosthesis made of siliconized homologous vein or bovine sacral artery.
    Kruse J; Borsow J; Buntrock P; Matthes G; Warnke H; Wenzel M
    Thorac Cardiovasc Surg; 1991 Dec; 39 Suppl 3():233-5. PubMed ID: 1803635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortocoronary bypass grafting with expanded polytetrafluoroethylene: 12-year patency.
    McLarty AJ; Phillips MR; Holmes DR; Schaff HV
    Ann Thorac Surg; 1998 May; 65(5):1442-4. PubMed ID: 9594884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortocoronary Gore-Tex graft: 18-month patency.
    Islam MN; Zikria EA; Sullivan ME; Koimattur A; Ford WB; Samadani SR; Miller WH
    Ann Thorac Surg; 1981 Jun; 31(6):569-73. PubMed ID: 6972748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative conduits for aortocoronary bypass grafting.
    Foster ED; Kranc MA
    Circulation; 1989 Jun; 79(6 Pt 2):I34-9. PubMed ID: 2655979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortocoronary bypass grafting with hydrophilic small caliber vascular grafts.
    Tomizawa Y; Noishiki Y; Okoshi T; Miyata T; Koyanagi H
    ASAIO Trans; 1989; 35(3):199-202. PubMed ID: 2597444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency coronary revascularization using polytetrafluoroethylene conduits in a patient in cardiogenic shock.
    Hartman AR; Vlay SC; Dervan JP; Lawson WE; Mannisi J; Anagnostopoulos CE
    Clin Cardiol; 1991 Jan; 14(1):75-8. PubMed ID: 2019033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary bypass grafting with biological grafts in a canine model.
    Tomizawa Y; Moon MR; DeAnda A; Castro LJ; Kosek J; Miller DC
    Circulation; 1994 Nov; 90(5 Pt 2):II160-6. PubMed ID: 7955246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts.
    Laube HR; Duwe J; Rutsch W; Konertz W
    J Thorac Cardiovasc Surg; 2000 Jul; 120(1):134-41. PubMed ID: 10884666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass grafting with an expanded polytetrafluoroethylene graft.
    Weyand M; Kerber S; Schmid C; Rolf N; Scheld HH
    Ann Thorac Surg; 1999 May; 67(5):1240-4; discussion 1244-5. PubMed ID: 10355390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical alternative bypass conduits and methods for surgical coronary revascularization.
    Nishida H; Grooters RK; Soltanzadeh H; Thiemen KC; Schneider RF
    Surg Gynecol Obstet; 1991 Feb; 172(2):161-74. PubMed ID: 1671177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological mapping of porcine carotid arteries - An animal model for the assessment of artificial conduits suitable for coronary bypass grafting in humans.
    Tomášek P; Tonar Z; Grajciarová M; Kural T; Turek D; Horáková J; Pálek R; Eberlová L; Králíčková M; Liška V
    Ann Anat; 2020 Mar; 228():151434. PubMed ID: 31704146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients.
    Chard RB; Johnson DC; Nunn GR; Cartmill TB
    J Thorac Cardiovasc Surg; 1987 Jul; 94(1):132-4. PubMed ID: 3496497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small caliber vascular grafts. Part I: state of the art.
    Zdrahala RJ
    J Biomater Appl; 1996 Apr; 10(4):309-29. PubMed ID: 8859403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioengineered vascular grafts: can we make them off-the-shelf?
    Dahl SL; Blum JL; Niklason LE
    Trends Cardiovasc Med; 2011 Apr; 21(3):83-9. PubMed ID: 22626247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits.
    Lorusso R; Pentiricci S; Raddino R; Scarabelli TM; Zambelli C; Villanacci V; Burattin A; Romanelli G; Casari S; Scelsi R; Giustina A
    Diabetes; 2003 Nov; 52(11):2814-20. PubMed ID: 14578301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term patency (9 1/2 years) and atherosclerosis of a polytetrafluoroethylene (Gortex) coronary artery bypass graft.
    Vlay SC; Malik AZ
    Clin Cardiol; 1998 Jan; 21(1):60-2. PubMed ID: 9474468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Configurations and classifications of composite arterial grafts in coronary bypass surgery.
    Yuan SM; Shinfeld A; Raanani E
    J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):3-14. PubMed ID: 18268413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.